iCo Therapeutics Inc. (iCo) is a Canada-based biotechnology company principally focused on the identification, development and commercialization of drug candidates to treat sight-and life-threatening diseases. The Company principally focuses on in-licensing drug candidates with a clinical history, and re-dose, reformulate and develop drug candidates for the treatment of sight-and life-threatening diseases. The Company's product candidates include iCo-007, iCo-008 and an Oral AmpB Delivery System. The Company has initiated Phase II clinical trial for iCo-007. iCo-008 is a human monoclonal antibody that is offered to treat sight threatening forms of allergic conjunctivitis by neutralizing eotaxin-1, a ligand to the chemokine receptor CCR3. Oral AmpB Delivery System is a toxic option for the treatment of serious systemic fungal infections. The Company has completed pre-clinical studies for iCo's Oral AmpB Delivery System.
Industry, Sector and Symbol:
Capitalization:- Market Cap: $2.61 million
- Outstanding Shares: 84,457,000
Average Prices:- 50 Day Moving Avg: $0.03
- 200 Day Moving Avg: $0.03
- 52 Week Range: $0.02 - $0.07
P/E:- Trailing P/E Ratio: N/A
- P/E Growth: 0.0000
Sales & Book Value:- Annual Revenue: N/A
- Price / Sales: N/A
- Book Value: $0.02 per share
- Price / Book: 1.55
Profitability:- EBIDTA: ($883,699.00)
- Return on Equity: -59.51%
- Return on Assets: -57.48%
Debt:- Current Ratio: 18.36%
- Quick Ratio: 18.36%
Misc:- Average Volume: 2,659 shs.
- Beta: 2.57
Frequently Asked Questions for iCo Therapeutics (OTCMKTS:ICOTF)
What is iCo Therapeutics' stock symbol?
iCo Therapeutics trades on the OTCMKTS under the ticker symbol "ICOTF."
How were iCo Therapeutics' earnings last quarter?
Who are some of iCo Therapeutics' key competitors?
Some companies that are related to iCo Therapeutics include Opexa Therapeutics (OPXA), Neurometrix (NURO), InspireMD (NSPR), Rosetta Genomics (ROSG), Prana Biotechnology Limited (PRAN), Delcath Systems (DCTH), Affymax (AFFY), Dextera Surgical (DXTR), Tetralogic Pharmaceuticals Corp (TLOG), Adeptus Health (ADPT), Aegerion Pharmaceuticals (AEGR), Air Methods Corp (AIRM), Alphatec Holdings (ATEC), Ariad Pharmaceuticals (ARIA), Caladrius Biosciences (CLBS), Celator Pharmaceuticals (CPXX), Cepheid (CPHD) and CoLucid Pharmaceuticals (CLCD).
How do I buy iCo Therapeutics stock?
Shares of iCo Therapeutics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of iCo Therapeutics stock cost?
One share of iCo Therapeutics stock can currently be purchased for approximately $0.03.
Consensus Ratings for iCo Therapeutics (OTCMKTS:ICOTF) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.| Ratings Breakdown: | No ratings tracked in the last 12 months. |
| Consensus Rating: | N/A (Score: NaN) |
| Consensus Price Target: | N/A |
Analysts' Ratings History for iCo Therapeutics (OTCMKTS:ICOTF)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for iCo Therapeutics (OTCMKTS:ICOTF)Earnings History by Quarter for iCo Therapeutics (OTCMKTS:ICOTF)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 5/29/2014 | Q1 2014 | ($0.02) | ($0.01) | | | View | N/A |  |
| 4/24/2014 | Q4 2013 | ($0.02) | ($0.02) | | | View | N/A | |
| 11/27/2013 | Q3 | | ($0.01) | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for iCo Therapeutics (OTCMKTS:ICOTF)No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for iCo Therapeutics (OTCMKTS:ICOTF)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for iCo Therapeutics (OTCMKTS:ICOTF)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for iCo Therapeutics (OTCMKTS:ICOTF)
Latest Headlines for iCo Therapeutics (OTCMKTS:ICOTF)
| Source: |
|
iCo Therapeutics (ICOTF) Chart for Saturday, May, 27, 2017
